Monday, November 23, 2020
Home Tags Inhibitors

Tag: Inhibitors

BCL-2 (B-cell lymphoma 2) Inhibitors Market 2020 key players – AbbVie...

BCL-2 (B-cell lymphoma 2) Inhibitors Market forecast to 2027 The Global BCL-2 (B-cell lymphoma 2) Inhibitors Market report provides information about the Global industry, including...

IL-23 Inhibitors Take Over the US Psoriasis Switching Market at the...

EXTON, Pa., Nov. 17, 2020 /PRNewswire/ -- The 2020 audit included in Spherix's RealWorld Dynamix™: Biologic/Small Molecule Switching in Psoriasis (US) service focuses on a...

B-cell Lymphoma 2 Inhibitors Market Size, Drivers, Potential Growth Opportunities, Competitive...

B-cell Lymphoma 2 Inhibitors Market Overview The Global B-cell Lymphoma 2 Inhibitors Market is showing positive signs of growth. With the current COVID-19 pandemic scenario,...

Immune Checkpoint Inhibitors Caused Bad Reaction In ‘Country Ever After’s’ Criscilla...

Extending Life But With Possibly Serious Side EffectsCheckpoint...

KRAS Inhibitors Show Promise in Early Studies

After three decades of unsuccessful attempts,...

Real-World Data Support Use of Multikinase Inhibitors in Differentiated Thyroid Cancer...

The mainstay for treatment in differentiated thyroid cancer (DTC) has been multikinase inhibitors (MKIs) for several years, although their effectiveness compared with targeted therapies...

SGLT2 Inhibitors Shown to Reduce Risk of Heart Attacks and Strokes...

With Amy Hess-Fischl RD The diabetes medication cut in half the risk of heart failure and other cardiac events in a comprehensive new study It's no secret that...

Dr. Martin on the Need for Head-to-Head Comparisons of BTK Inhibitors...

Peter Martin, MD, discusses the need for head-to-head comparison of BTK inhibitors in mantle cell lymphoma. Peter Martin, MD, chief, the Lymphoma Program, Meyer...

Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors

OSLO, Norway, Oct. 12, 2020 /PRNewswire/ -- Targovax ASA ("Targovax" or "the Company") (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to...

Reserve PARP Inhibitors for mCRPC With BRCA Mutations

For men with metastatic castration-resistant prostate cancer (mCRPC), any new therapy that offers the chance of a higher...
20,764FansLike
2,444FollowersFollow
16,600SubscribersSubscribe

EDITOR PICKS